A16P (p.Ala16Pro) variant of EGFR (Epidermal growth factor receptor)
A16P (p.Ala16Pro) in EGFR (Epidermal growth factor receptor) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The record also includes variant effect predictions and structural context.
A16P (p.Ala16Pro) variant details
- p.Ala16Pro
- Ensembl rs2128853424
- Uncertain significance
- Missense
- MetaLR 0.37
- MetaSVM -0.62
- SIFT 0.26
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Structural context available